Tag: myeloproliferative neoplasm

An Ocean of Hope For MPN Research

We’re posting a story about one of the participants in 23andMe’s MPN Research Initiative to bring attention to these rare diseases. September is National Blood Cancer Awareness Month, and today is MPN Awareness Day. Customers of 23andMe can help in these efforts — as well as our other research efforts with ...

Read more

One in Ten Lives with a Rare Disease

February 28 is Rare Disease Day — a concept first initiated by the European Rare Disease Organization (EURORDIS) and now recognized around the world. Around 6,800 rare diseases have been identified and up to 80% of them have a genetic origin. 23andMe provides genetic health reports for many of these ...

Read more

New Discoveries about Rare Blood Disorders from 23andMe

Editor’s note: Pending an FDA decision, 23andMe no longer offers new customers access to health reports referred to in this post. Customers who received their health information prior to November 22, 2013 will still be able to see their health reports, but those who purchased after that time will only have ...

Read more

Novel Genetic Findings for Myeloproliferative Neoplasms

Dave Hinds is a Principal Scientist in Statistical Genetics.  23andMe is passionate about research on a group of rare blood disorders called myeloproliferative neoplasms, or MPNs. Physicians who study these disorders consider them to be blood cancers, though individual prognoses can vary widely — some people ...

Read more

A Milestone in the Fight Against MPNs Marks a Moment to Reflect

Ashley Gould, 23andMe's Vice President Corporate Development and Chief Legal Officer We recently topped our goal of enrolling 1,000 people with a group of rare blood disorders known as myeloproliferative neoplasms, or MPNs. As a testament to the passion of the people who’ve enrolled in our MPN Research ...

Read more

Fighting Rare Blood Cancers

Dr. Ross Levine Last year 23andMe launched a Myeloproliferative Neoplasms Research Initiative to study this group of rare blood cancers. We are now very close to reaching our goal of enrolling 1,000 patients and are encouraged by what we’ve already learned. We’re also humbled that another star in the ...

Read more

Cancer Touches Everyone

23andMe is passionate about fighting cancer. We’re researching specific forms of cancer and treatments (see sidebar) and also learning more generally about cancer through our Cancer Family History survey (men’s version and women’s version). Personal experiences have the potential to fuel important research ...

Read more

National Cancer Research Awareness Month

Cancer is not one disease, but many. Even looking specifically at breast cancer or sarcoma, the more researchers study these diseases, the more they understand that there are many different kinds of breast cancer and sarcoma. This has been one of the most challenging aspects of researching cures for ...

Read more

Health Watch: New Year’s Resolutions, Reproduction and Rare Diseases

Like many people around the world, the health content team at 23andMe rang in 2012 with resolutions of staying healthy and it seemed fitting to delve into the genetics underlying response to diet and exercise, eating behavior and cholesterol levels. As we eased in to the new year, we segued into reproduction, ...

Read more

When DNA Discoveries Hit Close to Home

In August of last year, I wrote  with hope and excitement about the launch of the 23andMe MPN Research Initiative because my father, Harvey, suffers from myelofibrosis.  On March 5, 23andMe scientist Bethann Hromatka posted a SNPWatch report about the association between the JAK2 gene and MPNs. 23andMe ...

Read more

Return to top